Natural history of cervical squamous intraepithelial lesions: A meta- analysis

Obstetrics and Gynecology

Volumn 92, Issue 4 II SUPPL., 1998, Pages 727-735

  Melnikow, Joy ^a   Nuovo, James ^b   Willan, Andrew R ^b   Chan, Benjamin K S ^b   Howell, Lydia P ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GRADING; CANCER INVASION; COLPOSCOPY; HISTORY; HUMAN; META ANALYSIS; PRIORITY JOURNAL; REGRESSION ANALYSIS; REVIEW; SQUAMOUS CELL CARCINOMA; SQUAMOUS EPITHELIUM; UTERINE CERVIX CARCINOMA IN SITU;

EID: 0031684739     PISSN: 00297844     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0029-7844(98)00245-2     Document Type: Review

References (65)

1. Woolf SH. Screening for cervical cancer. In: Goldbloom RB, Lawrence RS, eds. Preventing disease: beyond the rhetoric. New York: Spring-Verlag, 1990:319-23.
2. Koss LG. The Papanicolaou test for cervical cancer detection. A triumph and a tragedy. JAMA 1989;261:737-43.
3. McGinnis JM, Lee PR. Healthy people 2000 at mid decade. JAMA 1995;273:1123-9.
4. Sadeghi SB, Sadeghi A, Robboy SJ. Prevalence of dysplasia and cancer of the cervix in a nationwide, planned parenthood population. Cancer 1988;61:2359-61.
5. Results from the National Breast and Cervical Cancer Early Detection Program, October 31, 1991-September 30, 1993. MMWR Morbid Mortal Wkly Rep 1994;43:530-4.
6. Kurman RJ, Henson DE, Herbst AL, Noller KL, Schiffman MH. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA 1994;271: 1866-9.
7. Miller AB, Anderson G, Brisson J, Laidlaw J, Le Pitre N, Malcolmson P, et al. Report of a national workshop on screening for cancer of the cervix. Can Med Assoc J 1991;145:1301-25.
8. American College of Obstetricians and Gynecologists. Cervical cytology: evaluation and management of abnormalities. ACOG technical bulletin no. 183. Washington, DC: American College of Obstetricians and Gynecologists, 1993.
9. Brown MS, Phillips GL Jr. Management of the mildly abnormal Pap smear: a conservative approach. Gynecol Oncol 1985;22:149-53.
10. Melnikow J, Nuovo J, Paliescheskey M. Management choices for patients with "squamous atypia" on Papanicolaou smear. A toss up? Med Care 1996;34:336-47.
11. Shafi MI, Luesley DM, Jordan JA. Mild cervical cytological abnormalities. BMJ 1992;305:1040-1.
12. Richart RM, Wright TC Jr. Controversies in the management of low-grade cervical intraepithelial neoplasia. Cancer 1993;71:1413-21.
13. Jones MH, Jenkins D, Cuzick J, Wolfendale MR, Jones JJ, BalogunLynch C, et al. Mild cervical dyskaryosis: safety of cytological surveillance. Lancet 1992;339:1440-3.
14. Spitzer M, Krumholz BA, Chernys AE, Seltzer V, Lightman AR. Comparative utility of repeat Papanicolaou smears, cervicography, and colposcopy in the evaluation of atypical Papanicolaou smears. Obstet Gynecol 1987;69:731-5.
15. Flannelly G, Kitchener H. Every woman with an abnormal cervical smear should be referred for treatment: debate. Clin Obstet Gynecol 1995;38:585-91.
16. Ferenczy A. Management of the patient with an abnormal Papanicolaou test. Recent developments. Obstet Gynecol Clin North Am 1993;20:189-202.
17. Kiviat N. Natural history of cervical neoplasia: overview and update. Am J Obstet Gynecol 1996;175:1099-104.
18. Reiter RC. Management of initial atypical cervical cytology: a randomized, prospective study. Obstet Gynecol 1986;68:237-40.
19. Hirschowitz L, Raffle AE, Mackenzie EF, Hughes AO. Long term follow up of women with borderline cervical smear test results: effects of age and viral infection on progression to high grade dyskaryosis. BMJ 1992;304:1209-12.
20. Montz FJ, Monk BJ, Fowler JM, Nguyen L. Natural history of the minimally abnormal Papanicolaou smear. Obstet Gynecol 1992;80: 385-8.
21. Howell LP, Davis RL. Follow-up of Papanicolaou smears diagnosed as atypical squamous cells of undetermined significance. Diagn Cytopathol 1996;14:20-4.
22. Noda K, Yajima A, Higashiiwai H, Sato A, Teshima K. Histopathologic criterion of dysplasia of the uterine cervix and its biological nature. Acta Cytol 1976;20:224-8.
23. Campion MJ, McCance DJ, Cuzick J, Singer A. Progressive potential of mild cervical atypia: prospective cytological, colposcopic, and virological study. Lancet 1986;2:237-40.
24. Nasiell K, Roger V, Nasiell M. Behavior of mild cervical dysplasia during long-term follow-up. Obstet Gynecol 1986;67:665-9.
25. Robertson JH, Woodend BE, Crozier EH, Hutchinson J. Risk of cervical cancer associated with mild dyskaryosis. BMJ 1988;297: 18-21.
26. Cooper P, Kirby AJ, Spiegelhalter DJ, Whitehead AL, Patterson A. Management of women with a cervical smear showing a mild degree of dyskaryosis: a review of policy. Cytopathology 1992;3: 331-9.
27. Holowaty PH. The natural history of cervical dysplasia [Dissertation]. Toronto: University of Toronto, 1996.
28. Kinlen LJ, Spriggs AI. Women with positive cervical smears but without surgical intervention. A follow-up study. Lancet 1978;2: 463-5.
29. Heinzl S, Szalmay G, Jochum L, Roemer V. Observations on the development of dysplasia. Acta Cytol 1982;26:453-6.
30. Nasiell K, Nasiell M, Vaclavinkova V. Behavior of moderate cervical dysplasia during long-term follow-up. Obstet Gynecol 1983;61:609-14.
31. Luthra UK, Prabhakar AK, Seth P, Agarwal SS, Murthy NS, Bhatnagar P, et al. Natural history of precancerous and early cancerous lesions of the uterine cervix. Acta Cytol 1987;31:226-34.
32. Figge DC. Long-range studies of the biologic behavior of the human uterine cervix. Obstet Gynecol 1962;108:422-8.
33. Fox CH. Biologic behavior of dysplasia and carcinoma in situ. Am J Obstet Gynecol 1967;99:960-74.
34. Galvin GA, Jones HW, Te Linde RW. The significance of basal-cell hyperactivity in cervical biopsies. Am J Obstet Gynecol 1955;70: 808-21.
35. Hall JE, Walton L. Dysplasia of the cervix: a prospective study of 206 cases. Am J Obstet Gynecol 1968;100:662-71.
36. Hulka BS. Cytologic and histologic outcome following an atypical cervical smear. Am J Obstet Gynecol 1968;101:190-9.
37. Johnson LD, Nickerson RJ, Easterday CL, Stuart RS, Hertig AT. Epidemiologic evidence for the spectrum of change from dysplasia through carcinoma in situ to invasive cancer. Cancer 1968;22:901-14.
38. Jordan MJ, Bader GM, Day E. Carcinoma in situ of the cervix and related lesions. Am J Obstet Gynecol 1964;89:160-82.
39. Koss LG, Stewart FW, Foote FW, Jordan MJ, Bader GM, Day E. Some histological aspects of behavior of epidermoid carcinoma in situ and related lesions of the uteri cervix. Cancer 1963;16:1160-211.
40. Masterson JG. An analysis of untreated intra-epithelial carcinoma of the cervix. In: Proceedings of the Third National Cancer Conference. Detroit: Lippincott, 1957:671-3.
41. McKay DG, Terjanian B, Poschyachinda D, Younge PA, Hertig AT. Clinical and pathologic significance of anaplasia (atypical hyperplasia) of the cervix uteri. Obstet Gynecol 1959;13:2-21.
42. Neiburgs HE. The significance of tissue cell changes preceding uterine cervix carcinoma. Cancer 1963;16:141-59.
43. Petersen O. Spontaneous course of cervical precancerous conditions. Am J Obstet Gynecol 1956;72:1063-71.
44. Sedlis A, Cohen A, Sall S. The fate of cervical dysplasia. Am J Obstet Gynecol 1970;107:1065-70.
45. Stern E. Dysplasia of the uterine cervix: incidence of regression, recurrence, and cancer. Cancer 1964;17:508-12.
46. Cotton RE, Elwood JM, Jones GM. Results of delayed follow up of abnormal cervical smears. BMJ (Clin Res Ed) 1986;292:799-800.
47. Fletcher A, Metaxas N, Grubb C, Chamberlain J. Four and a half year follow up of women with dyskaryotic cervical smears. BMJ 1990;301:641-4.
48. Kirby AJ, Spiegelhalter DJ, Day NE, Fenton L, Swanson K, Mann EM, et al. Conservative treatment of mild/moderate cervical dyskaryosis: long-term outcome. Lancet 1992;339:828-31.
49. Macgregor JE, Teper S. Uterine cervical cytology and young women. Lancet 1978;1:1029-31.
50. Morrison BJ, Coldman AJ, Boyes DA, Anderson GH. Forty years of repeated screening: the significance of carcinoma in situ. Br J Cancer 1996;74:814-9.
51. Flannelly G, Anderson D, Kitchener HC, Mann EM, Campbell M, Fisher P, et al. Management of women with mild and moderate cervical dyskaryosis. BMJ 1994;308:1399-403.
52. Maguire NC. Current use of the Papanicolaou class system in gynecologic cytology. Diagn Cytopathol 1988;4:169-76.
53. The 1988 Bethesda System for reporting cervical/vaginal cytological diagnoses. National Cancer Institute Workshop. JAMA 1989; 262:931-4.
54. Hudak PL, Cole DC, Haines AT. Understanding prognosis to improve rehabilitation: the example of lateral elbow pain. Arch Phys Med Rehabil 1996;77:586-93.
55. Raudenbush SW. Random effects models. In: Cooper HM, Hedges LV, eds. The handbook of research synthesis. New York: Russell Sage Foundation, 1994:301-21.
56. Schenk U, Herbert A, Solomon D, Amma NS, Collins RJ, Gupta SK, et al. Terminology: International Academy of Cytology Task Force Summary. Diagnostic cytology towards the 21st century: an international expert conference and tutorial. Acta Cytol 1998;42:5-15
57. DerSimonian R, Laird N. Meta-analysis in clinical trials. Controlled Clin Trials 1986;7:177-88.
58. Fleiss JL. The statistical basis of meta-analysis. Stat Methods Med Res 1993;2:121-45.
59. Ostor AG. Natural history of cervical intraepithelial neoplasia: A critical review. Int J Gynecol Pathol 1993;12:186-92.
60. Soutter WP, Fletcher A. Invasive cancer of the cervix in women with mild dyskaryosis followed up cytologically. BMJ 1994;308: 1421-3.
61. Sheils LA, Wilbur DC. Atypical squamous cells of undetermined significance. Acta Cytol 1997;47:1065-72.
62. Colditz GA, Burdick E, Mosteller F. Heterogeneity in meta-analysis of data from epidemiologic studies: A commentary. Am J Epidemiol 1995;142:371-82.
63. Jones DR. Meta-analysis of observational epidemiological studies: A review. J R Soc Med 1992;85:165-8.
64. Begg CB. Publication bias. In: Cooper HM, Hedges LV, eds. The handbook of research synthesis. New York: Russell Sage Foundation 1994:400-9.
65. Gregoire G, Derderian F, Le Lorier J. Selecting the language of the publications included in a meta-analysis: Is there a Tower of Babel bias? J Clin Epidemiol 1995;48:159-63.